Atlas Trials

Hemolytic Anemia

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hemolytic Anemia

RecordFirmDate
The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic Anemia (NCT05004259)Dartmouth-Hitchcock Medical Center2022-03-21
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat (NCT04610866)National Heart, Lung, and Blood Institute (NHLBI)2020-12-09
Immunoglobulin Dosage and Administration Form in CIDP and MMN (NCT02111590)Rigshospitalet, Denmark2014-01-01
Congenital Hemolytic and Dyserythropoietic Anemias (NCT07649213)Children's Hospital Medical Center, Cincinnati2011-07-25
Long Term Effects of Erythrocyte Lysis (NCT00842621)St. Jude Children's Research Hospital2009-03-01
Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients (NCT00110617)Novartis Pharmaceuticals2005-05-01
Combination Drug Therapy for Patients With Hepatitis C (NCT00001729)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1997-10-01

Track Hemolytic Anemia automatically

Every clearance here is in the API, with alerts when new ones post.